Table 1.
Clinical parameters in the groups.
| Variables | DM1 (n = 98) | DM2 (n = 137) | Control (n = 82) |
|---|---|---|---|
| Age, years | 55.8 (54.4–57.3) | 58.4 (57.3–59.5) | 55.9 (54.2–57.7) |
| Sex, male : female | 41 : 57 | 52 : 85 | 39 : 43 |
| BMI, kg/m2 | 26.1 (25.6–26.5) | 30.0 (29.4–30.6) | 28.7 (27.9–29.5) |
| Duration of DM, years | 16.6 (15.4–17.8) | 8.1 (7.2–8.8) | |
| HbA1c, mmol/mol | 57 (54–62) | 58 (55–62) | 30 (28–31) |
| Calcium2+, mmol/L | 1.09 (1.07–1.11)∗ | 1.06 (1.03–1.08) | 1.13 (1.11–1.15) |
| Phosphate, mmol/L | 5.4 (5.2–5.6)∗ | 4.9 (4.7–5.1) | 5.1 (4.9–5.2) |
| Magnesium, mmol/L | 0.63 (0.57–0.68)∗ | 0.63 (0.6–0.67) | 0.72 (0.66–0.78) |
| Potassium, mmol/L | 4.4 (4.2–4.6)∗ | 4.3 (4.1–4.4) | 4.3 (4.1–4.5) |
| Sodium, mmol/L | 142.2 (140.6–143.8)∗ | 140.9 (139.6–142.3) | 138.5 (137.2–139.6) |
| Creatinine, umol/L | 72.5 (69.85–76.04)∗ | 69.85 (67.2–72.5) | 66.32 (63.66–68.97) |
| eGFR, mL/min/1.73 | 87.9 (84.1–91.7)∗ | 88.5 (85.4–91.5)∗ | 95.2 (91.8–98.6) |
| Albumin, g/L | 42 (41–43)∗ | 43 (41–44)∗ | 45 (43–46) |
∗ p < 0.05 compared with the control group data.